Clinical Trials Browser

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Gulf War Illness

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2

Breast Cancer Female

Carcinoma, Non-Small-Cell Lung

ACTH Syndrome, Ectopic, Cushing Syndrome

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Breast Neoplasms, Breast Neoplasms, Male

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Fallopian Tube Neoplasms, Breast Neoplasms, Male

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Choristoma, Cushing Syndrome, Hirsutism, Pituitary Diseases, Pituitary ACTH Hypersecretion

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary Diseases, Pituitary ACTH Hypersecretion

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Choristoma, Cushing Syndrome, Hirsutism, Pituitary Diseases, Pituitary ACTH Hypersecretion

Leiomyoma, Uterine Hemorrhage

Endometrial Neoplasms, Endometrial Stromal Tumors

Prostatic Neoplasms

Clinical Trials

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer

E/M

Trial of Mifepristone for Fibroids

Breast Cancer BRCA1 Carriers: a Pilot Study

Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer

MIPRA

BRCA1/2 and Effect of Mifepristone on the Breast

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

S9005 Mifepristone in Meningioma

Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer

Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer

Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas

The Effect of Mifepristone on Uterine Fibroids and Breast Tissue

Mifemyo_2

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

SEISMIC

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

Mifepristone for Patients With Endometrial Cancer and LGESS

Mifepristone (RU-486) in Androgen Independent Prostate Cancer

Mifemyo